2016 Hematological Malignancies

1577 / 1835

Treatment Compliance
614 target sites*
randomised
299 24Gy 315 4Gy
5 withdrew 3 withdrew
289 (98.3%)
received full
protocol
treatment
305 (97.8%)
received full
protocol
treatment
* 548 unique patients.
21